ACCU-BREAK Pharmaceuticals, Inc.
1000 South Pine Island Road
Suite 430
Plantation
Florida
33324
United States
Tel: 954-236-7351
Fax: 954-236-7371
10 articles about ACCU-BREAK Pharmaceuticals, Inc.
-
ACCU-BREAK Pharmaceuticals, Inc. Files NDA For Unique Warfarin Potassium Tablets
11/19/2015
-
ACCU-BREAK Pharmaceuticals, Inc. Enters Into a Product Development and License Agreement With Alembic Pharmaceuticals Limited
8/6/2012
-
IpAuctions to Sell Six Medical Patent Applications on Behalf of ACCU-BREAK Pharmaceuticals, Inc.
6/12/2009
-
ACCU-BREAK Pharmaceuticals, Inc. Announces European Cooperation Agreement with Midas Pharma GmbH
2/20/2008
-
ACCU-BREAK Pharmaceuticals, Inc. Issued First Two Patents for Its Accu-Break(TM) Technologies
2/14/2008
-
Azopharma Product Development Group and ACCU-BREAK Pharmaceuticals, Inc. Announce Strategic Alliance Partnership
1/18/2008
-
ACCU-BREAK Pharmaceuticals, Inc. Tablet-Splitting Technologies Introduced at 2007 American Society of Hypertension Meeting
5/21/2007
-
India's Strides Arcolab Limited Ends Joint Venture with ACCU-BREAK Pharmaceuticals, Inc.
5/2/2007
-
ACCU-BREAK Pharmaceuticals, Inc. Announces Appointment Of Lawrence Rosenthal, Former President Of Andrx Pharmaceuticals, Inc.
11/30/2006
-
ACCU-BREAK Pharmaceuticals, Inc. And Strides Arcolab Limited Enter Into A Worldwide Joint Venture To Develop Generic Pharmaceuticals Using ACCU-BREAK(TM) Technologies
6/6/2006